(Q43044776)
Statements
1 reference
Benefit of erlotinib in patients with non-small-cell lung cancer is related to smoking status, gender, skin rash and radiological response but not to histology and treatment line (English)
1 reference
Martin Faehling
1 reference
Robert Eckert
1 reference
Sabine Kuom
1 reference
Torsten Kamp
1 reference
Kathrin M Stoiber
1 reference
Christian Schumann
1 reference
4 June 2010
1 reference
1 reference
78
1 reference
3-4
1 reference
249-258
1 reference
Identifiers
1 reference
1 reference